Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 April 2024 | Story Anthony Mthembu | Photo Charl Devenish
Rea Parkies
Dr Reabetswe Parkies, Senior Officer in Marketing within the Faculty of Economic and Management Sciences at the University of the Free State (UFS), graduates with a PhD in Business Management at the April 2024 graduations.

The April 2024  graduations at the University of the Free State (UFS) mark a significant moment for graduates in the Faculty of Economic and Management Sciences (EMS),  including Dr Reabetswe Parkies, whose journey in attaining a PhD in Business Management has been one of dedication and perseverance.

Reflecting on the upcoming ceremony, Dr Parkies expressed mixed emotions, encapsulating the essence of her journey: ‘’As I prepare to walk across that stage, I'm filled with a mixture of emotions—excitement, pride, nostalgia, and perhaps a hint of apprehension about what lies ahead.’’ This moment represents the culmination of years of hard work and commitment to her academic pursuits.

Dr Parkies’s doctoral thesis, titled “Student self-employment in South Africa: A triple helix model, entrepreneurial competence and social support perspective,” delves into the complex dynamics of student entrepreneurship within the South African context. Her study aims to develop a comprehensive model for understanding self-employment, incorporating factors such as entrepreneurial competence, social support, and the role of the university, industry and government initiatives.

A culmination of years of hard work

The path to achieving her PhD was not without its challenges. Balancing her responsibilities as a Senior Officer in Marketing at the UFS with the demands of academic research required meticulous time management and personal sacrifice. ‘’As time went on, I found my rhythm and developed strategies to become more efficient and effective,’’ Dr Parkies explained. She credits her successful completion of the PhD to the unwavering support of her supervisors and her determination.

As she prepares to celebrate this milestone, Dr Parkies looks ahead to future contributions to her field. ’’By delving deeper into my area of expertise, I aim to uncover new insights and share these findings with the academic community through scholarly articles,’’ she remarked, emphasising her commitment to ongoing research and knowledge dissemination.

Dr Reabetswe Parkies's achievement serves as an inspiration to aspiring scholars and underscores the importance of perseverance and dedication in pursuing academic excellence. Her journey exemplifies the ethos of the University of the Free State in fostering academic growth and scholarly inquiry. 

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept